With a sturdy scientific-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, such as Retrocyte Exhibit™ and SECANT®, and revolutionary cell therapy ways, positioning alone to be a crucial contributor from the biotechnology and immunotherapy arena.These built-in systems allow for the development of equally one-agent